Delivery Order SPE2DB24D2018-SPE2DB25FWWP7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $10,365.52 for the supply of Vaxelis vaccine in 0.5 milliliter vials. The award, made on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed pricing with no set-aside designation, indicating open competitive procurement. The delivery will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $2,557.92 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and utilized no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate...
- The Defense Logistics Agency awarded a $6,618.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with an ultimate completion date of September 10, 2025. This competitively awarded contract, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be performed at...
- This is a $3,177.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the VAXELIS vaccine in 0.5mL vials, with a performance period ending on June 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This delivery order, valued at $1,278.96, awards AmerisourceBergen Drug Corp a contract to supply Vaxelis vaccine syringes in 0.5ML quantities. The award was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. The Defense Logistics Agency, under the Department of Defense, is the funding federal agency, and performance will take place at the contractor's facility in Conshohocken,...
- This $3,586.26 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS Vaccine in 0.5mL vials, with a completion date of May 14, 2024. This contract award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- On September 12, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 0.5ML Vaxelis vaccine syringes with a ceiling value of $4,476.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and the...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWP7Delivery Order
The Defense Logistics Agency awarded a $3,499.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5 mL) with an ultimate completion date of September 9, 2025. This non-set-aside contract was awarded competitively on September 8, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical supply chain, particularly serving military and veteran healthcare systems through DLA and the Defense Health Agency. As the prime contractor under the comprehensive SPE2DX global pharmaceutical support vehicle, the company supplies a wide range of pharmaceutical products, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. This specific delivery order for Vaxelis vaccine vials aligns with the contractor's established portfolio of vaccine and medical supply distributions under the broader IDC agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/8/25 |